Lozivate-MF Lotion is a topical formulation containing Clobetasol propionate (0.05% w/v), Salicylic Acid (3% w/v), Lactic Acid (5% w/v), and Urea (10% w/v), designed for the management of various dermatological conditions. Clobetasol propionate, a potent corticosteroid, exerts strong anti-inflammatory, antipruritic, and vasoconstrictive effects, making it effective in reducing inflammation and itching associated with dermatoses such as psoriasis, eczema, and lichen planus. Salicylic Acid serves as a keratolytic agent, promoting exfoliation of hyperkeratotic skin and facilitating the penetration of other active ingredients. Lactic Acid, an alpha-hydroxy acid, aids in moisturizing and exfoliating the skin while restoring its natural pH balance. Urea acts as a humectant and keratolytic, enhancing skin hydration and softening thickened, scaly plaques. The combined action of these agents makes Lozivate-MF Lotion particularly suitable for treating hyperkeratotic and inflammatory skin disorders characterized by scaling, thickening, and itching. It should be applied as directed by a healthcare professional, avoiding prolonged use to minimize potential corticosteroid-related adverse effects such as skin atrophy. Contraindications include hypersensitivity to any component and use on infected or broken skin. Lozivate-MF Lotion offers a comprehensive approach to managing complex dermatological conditions requiring anti-inflammatory, keratolytic, and moisturizing therapy.